Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy.
Cannabidiol: promise and pitfalls.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Neurobehavioral disorders.
Can we measure long-term treatment effects in multiple sclerosis?
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Pediatric Multiple Sclerosis with Primary Progressive Course-Report of a Retrospective Cohort Study in Iran.
Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Primary CNS lymphoma masquerading as tumefactive demyelination.
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Time-Lapse Imaging of Glial-Axonal Interactions.
Statins and Neuroprotection: Basic Pharmacology Needed.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.

Pages